These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18398226)

  • 1. Methotrexate-induced alterations in beta-oxidation correlate with cognitive abilities in children with acute lymphoblastic leukemia.
    Moore IM; Miketova P; Hockenberry M; Krull K; Pasvogel A; Carey M; Kaemingk K
    Biol Res Nurs; 2008 Apr; 9(4):311-9. PubMed ID: 18398226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
    Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
    Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group.
    Duffner PK; Armstrong FD; Chen L; Helton KJ; Brecher ML; Bell B; Chauvenet AR
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):8-15. PubMed ID: 24345882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia.
    Miketova P; Kaemingk K; Hockenberry M; Pasvogel A; Hutter J; Krull K; Moore IM
    Biol Res Nurs; 2005 Jan; 6(3):187-95. PubMed ID: 15583359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.
    Kadan-Lottick NS; Brouwers P; Breiger D; Kaleita T; Dziura J; Northrup V; Chen L; Nicoletti M; Bostrom B; Stork L; Neglia JP
    J Clin Oncol; 2009 Dec; 27(35):5986-92. PubMed ID: 19884541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F2-isoprostanes: a measure of oxidative stress in children receiving treatment for leukemia.
    Hockenberry MJ; Taylor OA; Gundy PM; Ross AK; Pasvogel A; Montgomery D; Ribbeck P; McCarthy K; Moore I
    Biol Res Nurs; 2014 Jul; 16(3):303-9. PubMed ID: 23956352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive Sequelae in Adult Childhood Leukemia Survivors Related to Levels of Phosphorylated Tau.
    Elens I; Deprez S; Danckaerts M; Bijttebier P; Labarque V; Uyttebroeck A; Van Gool S; D'Hooge R; Lemiere J
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 29982754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
    Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
    Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intelligence quotient in childhood acute lymphoblastic leukemia after prophylactic treatment in central nervous system with 18 Gy cranial irradiation and intrathecal methotrexate.
    Liu HC; Liang DC; Chen SH; Lo CY; Tseng KP; Kuo TB; Chen HJ; Wang SJ
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(2):107-10. PubMed ID: 8935408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Late sequelae of CNS recurrence of acute lymphoblastic leukemia in childhood].
    Steinberg S; Hartmann R; Wisniewski S; Berger K; Beck JD; Henze G
    Klin Padiatr; 1998; 210(4):200-6. PubMed ID: 9743953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cross-sectional Study of Two Chemotherapy Protocols on Long Term Neurocognitive Functions in Egyptian Children Surviving Acute Lymphoblastic Leukemia.
    Sherief LM; Sanad R; ElHaddad A; Shebl A; Abdelkhalek ER; Elsafy ER; Hassan TH; Raafat N; Kamal NM; Attia EI
    Curr Pediatr Rev; 2018; 14(4):253-260. PubMed ID: 30381081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials.
    Vainionpää L; Kovala T; Tolonen U; Lanning M
    Med Pediatr Oncol; 1997 Jan; 28(1):41-7. PubMed ID: 8950335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-leukemic treatment-induced neurotoxicity in long-term survivors of childhood acute lymphoblastic leukemia: impact of reduced central nervous system radiotherapy and intermediate- to high-dose methotrexate.
    Zając-Spychała O; Pawlak M; Karmelita-Katulska K; Pilarczyk J; Jończyk-Potoczna K; Przepióra A; Derwich K; Wachowiak J
    Leuk Lymphoma; 2018 Oct; 59(10):2342-2351. PubMed ID: 29424258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies.
    Surtees R; Clelland J; Hann I
    J Clin Oncol; 1998 Apr; 16(4):1505-11. PubMed ID: 9552059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].
    Zając-Spychała O; Wachowiak J
    Med Wieku Rozwoj; 2012; 16(2):128-37. PubMed ID: 22971657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol.
    Montour-Proulx I; Kuehn SM; Keene DL; Barrowman NJ; Hsu E; Matzinger MA; Dunlap H; Halton JM
    J Child Neurol; 2005 Feb; 20(2):129-33. PubMed ID: 15794179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
    Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
    Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal methotrexate-induced acute chorea.
    Necioğlu Orken D; Yldrmak Y; Kenangil G; Kandraloğlu N; Forta H; Celik M
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):57-8. PubMed ID: 19125090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.
    Osterlundh G; Kjellmer I; Lannering B; Rosengren L; Nilsson UA; Márky I
    Pediatr Blood Cancer; 2008 Apr; 50(4):793-8. PubMed ID: 17973312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal methotrexate-induced acute cerebellar syndrome.
    Ferhanoglu B; Ongören S; Ar CM; Uzel B; Forta H; Necioglu D
    Ann Hematol; 2003 Apr; 82(4):241-3. PubMed ID: 12707728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.